Results 31 to 40 of about 669,979 (252)

The natural history of progressive fibrosing interstitial lung diseases

open access: yesEuropean Respiratory Journal, 2020
We used data from the INBUILD and INPULSIS trials to investigate the natural history of progressive fibrosing interstitial lung diseases (ILDs). Subjects in the two INPULSIS trials had a clinical diagnosis of idiopathic pulmonary fibrosis (IPF) while ...
K. Brown   +10 more
semanticscholar   +1 more source

Occupational interstitial lung diseases

open access: yesJournal of Internal Medicine, 2023
AbstractMillions of workers are exposed to substances known to cause occupational interstitial lung diseases (ILDs), particularly in developing countries. However, the burden of the disease is likely to be underestimated due to under‐recognition, under‐reporting or both.
Spagnolo, Paolo   +11 more
openaire   +4 more sources

Palliative care for people with non-malignant lung disease: summary of current evidence and future direction [PDF]

open access: yes, 2013
Background: The physical and psychosocial needs of patients with chronic non-malignant lung disease are comparable to those with lung cancer. This article will focus on chronic obstructive pulmonary disease, interstitial lung disease and cystic fibrosis ...
Boland, Jason   +5 more
core   +1 more source

Quantification of pulmonary disease activity in sarcoidosis measured with 18F-FDG PET/CT: SUVmax versus total lung glycolysis

open access: yesEJNMMI Research, 2019
Background 18F-FDG PET/CT has proven to be a reliable tool for therapy monitoring in sarcoidosis. Previous PET studies investigated the SUVmax as a marker for disease activity. Total lung glycolysis (TLuG) is a new tool, quantifying the glycolysis of the
Milou C. Schimmelpennink   +3 more
doaj   +1 more source

Progression of radiographic fibrosis in rheumatoid arthritis-associated interstitial lung disease

open access: yesFrontiers in Medicine, 2023
Background and objectivesPreclinical interstitial lung disease (pILD) may represent the early stages of rheumatoid arthritis-associated interstitial lung disease (RA-ILD).
Dandan Chai   +7 more
doaj   +1 more source

Multicenter Prospective Study of the Efficacy and Safety of Combined Immunosuppressive Therapy With High‐Dose Glucocorticoid, Tacrolimus, and Cyclophosphamide in Interstitial Lung Diseases Accompanied by Anti–Melanoma Differentiation–Associated Gene 5–Positive Dermatomyositis

open access: yesArthritis & Rheumatology, 2020
Interstitial lung disease (ILD) accompanied by anti–melanoma differentiation–associated gene 5 (anti–MDA‐5)–positive dermatomyositis (DM) is often rapidly progressive and associated with poor prognosis.
H. Tsuji   +20 more
semanticscholar   +1 more source

Telomerase Reverse Transcriptase Polymorphism rs2736100: A Balancing Act between Cancer and Non-Cancer Disease, a Meta-Analysis

open access: yesFrontiers in Medicine, 2018
The enzyme telomerase reverse transcriptase (TERT) is essential for telomere maintenance. In replicating cells, maintenance of telomere length is important for the preservation of vital genetic information and prevention of genomic instability.
Reinier Snetselaar   +5 more
doaj   +1 more source

The Role of Cutibacterium acnes in Sarcoidosis: From Antigen to Treatable Trait?

open access: yesMicroorganisms, 2022
Cutibacterium acnes (C. acnes, formerly Propionibacterium acnes) is considered to be a non-pathogenic resident of the human skin, as well as mucosal surfaces. However, it also has been demonstrated that C.
Raisa Kraaijvanger, Marcel Veltkamp
doaj   +1 more source

The role of nailfold capillaroscopy in interstitial lung diseases - Can it differentiate idiopathic cases from collagen tissue disease associated interstitial lung diseases? [PDF]

open access: yes, 2015
Introduction: Nailfold capillaroscopy (NFC) is a non-invasive diagnostic test that is mostly used for early diagnosis of collagen tissue diseases (CTDs). We aimed to evaluate whether NFC findings could be a clue for discriminating idiopathic interstitial
Altınışık, Göksel   +4 more
core   +1 more source

Efficacy and Tolerability of Methotrexate and Methylprednisolone in a Comparative Assessment of the Primary and Long-Term Outcomes in Patients with Pulmonary Sarcoidosis

open access: yesDiagnostics, 2021
Background: There is insufficient information in the literature on the comparative efficacy and tolerability of methotrexate (MTX) and methylprednisolone (MP) in patients with pulmonary sarcoidosis in assessing primary outcomes and the relapse rate ...
Volodymyr Gavrysyuk   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy